Car in Pieces

The Oncotarget Platform Allows Research Papers to Be Submitted and Evaluated

Oncotarget is a publisher who offers a platform for the submission and evaluation of scientific and medical papers in the field of oncology and other areas of medical study. Begun in 2010, Oncotarget has published 270 papers about oxygen related subject matter, for example.

Other topics that are open for research and publishing include geotargeting/aging, cardiology, metabolism, endocrinology, neuropathology/neuroscience, pharmacology, mol and cell biology, and immunology/microbiology.

All papers and manuscripts at are submitted to the Editorial Board for review and evaluation. The Editors-in-Chief are Andrei V. Gudkov and Mikhail V. Blagoskionny, both of the Roswell Park Cancer Institute in Buffalo, New York.

Once a manuscript is submitted to the editors, it is evaluated only by its merit from a scientific standpoint. There are no allowances for opinionated, political or prejudicial viewpoints on The article is evaluated strictly on its adherence to the scientific proposition put forward, rather than any factor of opinionated thought, race, sex, ethnicity, religious standpoint or governmental politics.

All hypotheses and viewpoints are to be backed up by evidence based upon experimentation or sources cited to support the hypothesis. The peer review process is extremely valuable because who else would have the background and expertise to judge the merit of the research and conclusions.

Scrutiny is given by the editors to ensure that there is no copyright infringement, conflicts of interest, defamation, prejudicial conclusions, plagiarism, fabrication or falsifications of any kind.

The results of an article should be clearly described by the author with a detailed narrative of how the conclusions were determined. Of course, all conclusions on must be meticulously supported with citations and conclusions. Care should be taken to avoid the publication of research and articles which show the same conclusions and research from work that already is in existence.

Oncotarget allows the research and publication of other supporting articles in the medical field that relate to oncology because of the complexity of the development of tumors. This is why such topics as endocrinology, age focused diseases, pathology, immunology, physiology and other similar topics are allowed.

Oncotarget offers free access on a weekly basis. The mission of Oncotarget is to make the knowledge as immediately available as possible so that maximum impact can be realized.

1 comment for “The Oncotarget Platform Allows Research Papers to Be Submitted and Evaluated

  1. Welch Jim
    January 13, 2017 at 7:45 pm

    It is important to share vital information and discoveries be available so that medical awareness and usefulness can be achieved as soon as possible. Evaluations are made by at least two peer reviewers who are experts in the field in which the article addresses. These evaluation process has made it easier for superior papers us to account for all the losses last year.